Celine Halioua
Founder and CEO of Loyal, USA
​ 
Celine is the founder and CEO of Loyal, a biotech startup developing drugs to extend dog lifespan. She is also dabble in biotech & deep-tech investing.

Before that, she was a DPhil student at Oxford studying the health economics of gene therapy (St Peter’s College) & Chief of Staff to Laura Deming at Longevity Fund. Celine studied neuroscience and nanobiotechnology at the University of Texas at Austin and Uppsala Universitet in Sweden. She worked in the laboratories of Dr. Evan Snyder at the Sanford Consortium of Regenerative Medicine on novel enteric neuron disease therapeutics, and of Dr. Richard Morrisett and Dr. Keith Stevenson at The University of Texas at Austin on the development of a novel fluorescent silver-nanocluster-based neuronal tracers.

She is interested in biotechnology, specifically unravelling and developing therapeutics for pathological aging. Celine is also interested in healthcare systems, specifically the application of socialized healthcare practices to the United States and the economic incentivization of preventative and curative medicine.

 
​ 
See the Speaker List